85719-40-0

Basic information

• Product Name: dibenzyl (2S)-2-hydroxybutanedioate
• Synonyms: dibenzyl (2S)-2-hydroxybutanedioate
• CAS NO: 85719-40-0
• Molecular Weight: 314.338
• Mol File: 85719-40-0.mol

Chemical Properties

• CAS DataBase Reference: dibenzyl (2S)-2-hydroxybutanedioate(CAS DataBase Reference)
• NIST Chemistry Reference: dibenzyl (2S)-2-hydroxybutanedioate(85719-40-0)
• EPA Substance Registry System: dibenzyl (2S)-2-hydroxybutanedioate(85719-40-0)

Safety Data

• Hazardous Substances Data: 85719-40-0(Hazardous Substances Data)

Upstream product

• 97-67-6 (S)-Malic acid 
• 100-39-0 benzyl bromide 
• 100-51-6 benzyl alcohol 

Downstream Products

• 136010-67-8 (2R,3S)-2-benzyl-3-hydroxysuccinic acid 
• 1003002-78-5 (2S)-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-(4-t-butylphenyl)-1-propanol 
• 1610595-72-6 C₁₆H₂₄O₃ 
• 1003002-77-4 (2S)-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-phenyl-1-propanol 
• 1446436-14-1 C₂₀H₁₈O₅ 
• 1365265-70-8 dibenzyl 2-benzylidenesuccinate 
• 1365265-51-5 (E)-dibenzyl 2-benzylfumarate 
• 1365265-58-2 C₂₅H₂₄O₆ 
• 1365265-55-9 (2S,3S)-dibenzyl 2-benzyl-2-hydroxy-3-(4-methylphenylsulfonamido)succinate 
• 1326706-35-7 2-(S)-(3,4,6-tri-O-benzyl-2-azido-2-deoxy-α-D-glucopyranosyl)-butan-1,4-dioic acid dibenzyl ester 
• 1326706-34-6 2-(S)-(3,4,6-tri-O-acetyl-2-azido-2-deoxy-α-D-glucopyranosyl)-butan-1,4-dioic acid dibenzyl ester 
• 1003002-75-2 dibenzyl (2S,3R)-2-(4-t-butylbenzyl)-3-hydroxybutanedioate 
• 172275-56-8 dibenzyl (2S,3R)-2-benzyl-3-hydroxybutanedioate 
• 133039-06-2 (S)-benzyl 3-hydroxy-4-(tosyloxy)butanoate 

Relevant articles and documents

Enzymatic Polymerization of an Ibuprofen-Containing Monomer and Subsequent Drug Release

Novel ibuprofen-containing monomers comprising naturally occurring and biocompatible compounds were synthesized and subsequently polymerized via enzymatic methods. Through the use of a malic acid sugar backbone, ibuprofen was attached as a pendant group,

Selective Monoacylation of Diols and Asymmetric Desymmetrization of Dialkyl meso-Tartrates Using 2-Pyridyl Esters as Acylating Agents and Metal Carboxylates as Catalysts

With 2-pyridyl benzoates as acylating agents and Zn(OAc)2 as a catalyst, 1,2-diols, 1,3-diols, and catechol were selectively monoacylated. Furthermore, the highly enantioselective desymmetrization of meso-tartrates was achieved for the first time, utilizing 2-pyridyl esters and NiBr2/AgOPiv/Ph-BOX in CH3CN or CuCl2/AgOPiv/Ph-BOX in EtOAc catalyst systems (up to 96% ee). The latter catalyst system was also effective for the kinetic resolution of dibenzyl dl-tartrate.

Peniphenone and Penilactone Formation in Penicillium crustosum via 1,4-Michael Additions of ortho-Quinone Methide from Hydroxyclavatol to γ-Butyrolactones from Crustosic Acid

Penilactones A and B consist of a γ-butyrolactone and two clavatol moieties. We identified two separate gene clusters for the biosynthesis of these key building blocks in Penicillium crustosum. Gene deletion, feeding experiments, and biochemical investiga

Synthesis of orthogonally protected (2S)-2-amino-adipic acid (α-AAA) and (2S,4 R)-2-amino-4-hydroxyadipic acid (Ahad)

(2S,4R)-2-Amino-4-hydroxyadipic acid (Ahad) building block 45 was synthesized in 11 steps and 6.5% overall yield from commercially available materials. Key steps in stereocontrol were an asymmetric conjugate addition employing a proline-based catalyst and a syn-selective intramolecular-conjugate addition of an oxygen nucleophile to an α,β-unsaturated ester. To enable incorporation of α-amino-adipic acid (α-AAA) and Ahad into peptides, a truly orthogonal protecting group scheme was developed, encompassing an allyloxycarbonyl (Alloc) carbamate for Nα, a tert-butyl ester for the δ-COOH, an acetol ester for the α-COOH, and a tert- butyldimethylsilyl ether for the γ-hydroxy group of Ahad.

Straightforward total synthesis of 2-O-feruloyl-L-malate, 2-O-sinapoyl-L-malate and 2-O-5-hydroxyferuloyl-L-malate

A synthetic method for the preparation of 2-O-feruloylL-malic acid, 2-O-sinapoyl-L-malic acid and 2-O-5-hydroxyferuloyl-L-malic acid from malic acid and ferulic, sinapic, and hydroxyferulic acids, respectively, using Steglich esterification is described.

Stereospecific high-affinity TRPV1 antagonists: Chiral N-(2-benzyl-3- pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues

Previously, we reported the thiourea antagonists 2a and 2b as potent and high affinity TRPV1 antagonists. For further optimization of the lead compounds, a series of their amide and α-substituted amide surrogates were investigated and novel chiral N-(2-be

(2R,3S)- and (2S,3R)-2-benzyl-3,4-epoxybutanoic acid as highly efficient and fast acting pseudomechanism-based inactivators for carboxypeptidase A: design, asymmetric synthesis and inhibitory kinetics

2-benzyl-3,4-epoxybutanoic acid (BEBA) was studied as an irreversible inhibitor for the zinc-containing protease, carboxypeptidase A.Of four possible stereoisomers, those having a 2R,3S- and a 2S,3R- configuration inhibited carboxypeptidase A in a time-de

A new, short and efficient synthesis of both enantiomers of carnitine

A short, efficient and enantioselective synthesis of both (R) and (S) enantiomers of carnitine is reported starting with (R) or (S) malic acid and involving a chemoselective reduction step.